These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18391133)

  • 1. Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.
    Rohde P; Silva SG; Tonev ST; Kennard BD; Vitiello B; Kratochvil CJ; Reinecke MA; Curry JF; Simons AD; March JS
    Arch Gen Psychiatry; 2008 Apr; 65(4):447-55. PubMed ID: 18391133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating patient-specific treatment advantages in the 'Treatment for Adolescents with Depression Study'.
    Foster S; Mohler-Kuo M; Tay L; Hothorn T; Seibold H
    J Psychiatr Res; 2019 May; 112():61-70. PubMed ID: 30856378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
    Kratochvil C; Emslie G; Silva S; McNulty S; Walkup J; Curry J; Reinecke M; Vitiello B; Rohde P; Feeny N; Casat C; Pathak S; Weller E; May D; Mayes T; Robins M; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1412-8. PubMed ID: 17135986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating a broader range of depressed adolescents with combined therapy.
    Foster S; Mohler-Kuo M
    J Affect Disord; 2018 Dec; 241():417-424. PubMed ID: 30145512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).
    Lewis CC; Simons AD; Nguyen LJ; Murakami JL; Reid MW; Silva SG; March JS
    J Am Acad Child Adolesc Psychiatry; 2010 Feb; 49(2):132-40. PubMed ID: 20215935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
    March J; Silva S; Vitiello B;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.
    Kratochvil CJ; May DE; Silva SG; Madaan V; Puumala SE; Curry JF; Walkup J; Kepley H; Vitiello B; March JS
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):519-27. PubMed ID: 19877976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for Adolescents with Depression Study (TADS): safety results.
    Emslie G; Kratochvil C; Vitiello B; Silva S; Mayes T; McNulty S; Weller E; Waslick B; Casat C; Walkup J; Pathak S; Rohde P; Posner K; March J; ;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1440-55. PubMed ID: 17135989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
    Kennard B; Silva S; Vitiello B; Curry J; Kratochvil C; Simons A; Hughes J; Feeny N; Weller E; Sweeney M; Reinecke M; Pathak S; Ginsburg G; Emslie G; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1404-11. PubMed ID: 17135985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
    Petersen T; Harley R; Papakostas GI; Montoya HD; Fava M; Alpert JE
    Psychol Med; 2004 Apr; 34(3):555-61. PubMed ID: 15259840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
    Jarrett RB; Thase ME
    Contemp Clin Trials; 2010 Jul; 31(4):355-77. PubMed ID: 20451668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderators and Predictors of Response After 36 Weeks of Treatment in the Treatment for Adolescents with Depression Study (TADS).
    O'Dor SL; Washburn J; Howard KR; Reinecke MA
    Res Child Adolesc Psychopathol; 2021 Nov; 49(11):1489-1501. PubMed ID: 34050856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a data-driven algorithm for guiding selection between cognitive behavioral therapy, fluoxetine, and combination treatment for adolescent depression.
    Gunlicks-Stoessel M; Klimes-Dougan B; VanZomeren A; Ma S
    Transl Psychiatry; 2020 Sep; 10(1):321. PubMed ID: 32958758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
    Domino ME; Foster EM; Vitiello B; Kratochvil CJ; Burns BJ; Silva SG; Reinecke MA; March JS
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):711-720. PubMed ID: 19465880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Kocsis JH; Rush AJ; Markowitz JC; Borian FE; Dunner DL; Koran LM; Klein DN; Trivedi MH; Arnow B; Keitner G; Kornstein SG; Keller MB
    Psychopharmacol Bull; 2003; 37(4):73-87. PubMed ID: 15131518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
    Kennard BD; Emslie GJ; Mayes TL; Nightingale-Teresi J; Nakonezny PA; Hughes JL; Jones JM; Tao R; Stewart SM; Jarrett RB
    J Am Acad Child Adolesc Psychiatry; 2008 Dec; 47(12):1395-404. PubMed ID: 18978634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.